Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 102.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 2.00 (1.98%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 102.00
CNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Product Announcement

30 Jan 2017 09:23

RNS Number : 4475V
Concurrent Technologies PLC
30 January 2017
 

 

30 January 2017

Concurrent Technologies Plc

('Concurrent Technologies' or the 'Company')

 

Product Announcement

New Generation of Boards

 

Concurrent Technologies Plc (AIM: CNC), a world leading specialist in the design and manufacture of high-end embedded computer boards for critical applications in the defence, aerospace, telecommunications, transportation, scientific and industrial markets, is pleased to announce its next generation of boards which will be based around the latest generation Xeon® processor, recently launched by Intel®.

 

This family of Xeon® processors offers enhanced processing and graphics performance over earlier generations of processors. It provides the Company with an additional key design expertise which can be applied to many new boards. The processors are long life cycle devices, which is an essential requirement for the Company and its customers, who require boards to be available for at least 5 years, with further extended manufacturing and repair support for anything up to 15 years and beyond.

 

The Company's existing customers will benefit from the introduction of boards using this new Xeon® processor family for both upgrades and new products. Similarly, new customers will benefit from the enhanced performance and feature sets of the latest boards. 

 

The first board using this new Xeon® processor technology is expected to be available in March. This will be a MicroTCA® architecture board, targeted at both existing and new applications within the scientific market where the Company has been active for several years. MicroTCA® is widely used within this market and this new board will provide an upgrade path for both new and existing customers.

 

Glen Fawcett, CEO, Concurrent Technologies, commented:

"By supporting the newly announced Xeon® processor family, Concurrent Technologies continues to demonstrate its commitment to applying the latest Intel® technology suitable for our market sectors. Our product strategy was, and is, to rapidly take advantage of new processor families from Intel®, thus allowing our customers to enhance the capabilities of their products and helping them to get to market sooner."

 

 

Enquiries:

Concurrent Technologies PlcGlen Fawcett, CEO

 

+44 (0)1206 752 626

 

 

Newgate (Financial PR)Bob Huxford

Helena Bogle

+44 (0)207 653 9850

 

 

Cenkos Securities plc (NOMAD)Neil McDonald

Nick Tulloch/Beth McKiernan

+44 (0)131 220 9771

+44 (0)131 220 9772/8

 

Note to Editors:

 

About Concurrent Technologies Plc

 

Concurrent Technologies Plc develops and manufactures high-end embedded computer products for use in a wide range of high performance, long life cycle applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets, including applications within extremely harsh environments. The processor products traditionally feature Intel® processors, including the latest generation Intel® Core™ i7 processors, Intel® Xeon® and Intel® Atom™ processors. More recently NVIDIA® Tegra® K1 devices have been added to the product ranges along with complementary switch and I/O boards. The products are designed to be compliant with industry specifications and support many of today's leading embedded Operating Systems. The products are sold world-wide.

 

For more information on Concurrent Technologies Plc and its products please visit www.cct.co.uk

All trademarks, registered trademarks and trade names used in this announcement are the property of their respective owners.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PRLGCGDBDDXBGRG
Date   Source Headline
12th May 20227:00 amRNSResults for the year ended 31 December 2021
11th May 20227:00 amRNSInvestor Presentation
9th May 20227:00 amRNSConfirmation of Results Date and Board Appointment
24th Mar 202212:44 pmRNSNotice of Results
9th Mar 202210:36 amRNSContract Award
25th Feb 20227:00 amRNSProduct Announcement
21st Feb 20227:00 amRNSBoard Changes
26th Jan 20227:00 amRNSProduct Announcement
5th Jan 20227:00 amRNSPost-Close Trading Update
23rd Nov 20217:07 amRNSIssue of Share Options and PDMR Dealing
27th Sep 20213:12 pmRNSBoard Changes
7th Sep 20217:00 amRNSBoard Changes
7th Sep 20217:00 amRNSInterim Results
1st Sep 20211:20 pmRNSNotice of Results
10th Aug 202112:05 pmRNSHolding(s) in Company
4th Aug 20217:00 amRNSProduct Announcement
21st Jul 20217:00 amRNSBoard Changes
8th Jul 202111:15 amRNSHolding(s) in Company
23rd Jun 202111:58 amRNSIssue of share options and PDMR dealing
15th Jun 20214:19 pmRNSResult of AGM
15th Jun 202112:34 pmRNSAGM Statement
20th May 20217:00 amRNSPosting of Annual Report & Notice of AGM
12th May 20219:00 amRNSBoard Changes
12th Apr 20217:00 amRNSFinal Results
25th Mar 202110:50 amRNSNotification of Results
10th Mar 20217:00 amRNSSecond Interim Dividend
16th Dec 20207:00 amRNSPre-Close Trading Update
13th Nov 202011:58 amRNSDirector/PDMR Shareholding
5th Nov 20207:00 amRNSLaunch of high performance Advanced MC Board
21st Oct 20204:02 pmRNSTreasury Shares
20th Oct 20209:07 amRNSTreasury Shares
16th Oct 20207:00 amRNSIssue of Share Options and PDMR dealing
16th Oct 20207:00 amRNSTreasury Shares
6th Oct 20204:50 pmRNSTotal Voting Rights
11th Sep 20203:07 pmRNSDirector/PDMR Shareholding
2nd Sep 20207:00 amRNSInterim Results
21st Aug 20207:00 amRNSNotification of Interim Results
23rd Jul 202011:15 amRNSHolding(s) in Company
3rd Jul 20207:00 amRNSRetirement of Director
17th Jun 20202:33 pmRNSResult of AGM
16th Jun 20202:45 pmRNSAGM Statement
9th Jun 20205:17 pmRNSTotal Voting Rights & Director Shareholding
1st Jun 20207:00 amRNSHolding(s) in Company
29th May 20207:00 amRNSHolding(s) in Company
27th May 20204:55 pmRNSTotal Voting Rights & Director Shareholding
22nd May 20202:34 pmRNSPosting of Annual Report and Notice of AGM
22nd May 20207:00 amRNSDirector Appointment
12th May 20207:00 amRNSTotal Voting Rights
30th Apr 20206:18 pmRNSDirector/PDMR Shareholding
23rd Apr 20207:00 amRNSResults for the year ended 31 December 2019

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.